STOCK TITAN

Tenon Medical (TNON) director converts 10,732 RSUs into common stock

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Tenon Medical, Inc. director Stephen Hochschuler converted 10,732 restricted stock units granted on October 13, 2025 into 10,732 shares of common stock on July 31, 2026 at a stated price of $0.00 per share. After the conversion, he directly holds 18,670 shares of Tenon Medical common stock and no remaining units from this grant.

Positive

  • None.

Negative

  • None.
Insider Hochschuler Stephen
Role Director
Type Security Shares Price Value
Exercise Restricted Stock Units F1, F2 10,732 $0.00 $0.00
Exercise Common Stock F1 10,732 $0.00 $0.00
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); Common Stock — 18,670 shares (Direct)
Footnotes (2)
  1. F1. Represents conversion of 10,732 restricted stock units granted to the reporting person on October 13, 2025 into 10,732 shares of common stock of the Issuer on July 31, 2026.
  2. F2. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
Restricted stock units converted 10,732 units Conversion of restricted stock units into common stock on July 31, 2026
Common shares acquired via conversion 10,732 shares Shares of Tenon Medical common stock received from RSU conversion on July 31, 2026
Holdings after transaction 18,670 shares Direct Tenon Medical common stock holdings reported after the July 31, 2026 transactions
Reported per-share price $0.00 per share Stated price for the RSU conversion into common stock on July 31, 2026
Restricted Stock Units financial
"Conversion of 10,732 Restricted Stock Units into common stock on July 31, 2026."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"Transaction described as an exercise or conversion of derivative security."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What transaction did Tenon Medical (TNON) director Stephen Hochschuler report?

Stephen Hochschuler converted 10,732 restricted stock units into 10,732 shares of Tenon Medical common stock on July 31, 2026. The units were granted on October 13, 2025 and each represented a contingent right to receive one common share.

How many Tenon Medical (TNON) shares does Stephen Hochschuler own after this transaction?

After the July 31, 2026 conversion, Stephen Hochschuler directly holds 18,670 shares of Tenon Medical common stock. This reflects the addition of 10,732 shares received from converting restricted stock units and the elimination of those units from his reported holdings.

What was the price per share for Stephen Hochschuler’s Tenon Medical (TNON) RSU conversion?

The RSU conversion was reported at a stated price of $0.00 per share for the 10,732 shares of common stock. This reflects the nature of restricted stock units, which convert into shares rather than being purchased for cash in this transaction.

Were Stephen Hochschuler’s Tenon Medical (TNON) transactions under a Rule 10b5-1 plan?

These transactions were reported with the Rule 10b5-1 checkbox left unchecked, indicating they were not designated as being executed under a Rule 10b5-1 trading plan. No footnote describes any separate pre-arranged trading arrangement for this activity.

When were the restricted stock units granted to Stephen Hochschuler at Tenon Medical (TNON)?

The 10,732 restricted stock units converted on July 31, 2026 were granted on October 13, 2025. Each restricted stock unit represented a contingent right to receive one share of Tenon Medical common stock, as described in the transaction footnotes.

Did this transaction change Stephen Hochschuler’s restricted stock unit balance at Tenon Medical (TNON)?

Yes. The conversion of 10,732 restricted stock units into an equal number of common shares reduced his reported holdings of these units to zero. All 10,732 units from this specific grant are now reflected as common stock holdings instead.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hochschuler Stephen

(Last)(First)(Middle)
104 COOPER COURT

(Street)
LOS GATOS CALIFORNIA 95032

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Tenon Medical, Inc. [ TNON ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock(1)07/31/2026M10,732A$018,670D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)(2)07/31/2026M10,732 (1) (1)Common Stock10,732$00D
Explanation of Responses:
1. Represents conversion of 10,732 restricted stock units granted to the reporting person on October 13, 2025 into 10,732 shares of common stock of the Issuer on July 31, 2026.
2. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
/s/ Stephen Hochschuler08/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)